Dr Bernard Fox
Harder Family Chair for Cancer Research, Member and Chief, Laboratory of Molecular and Tumor Immunology
Robert W. Franz Cancer Center Earle A. Chiles Research Institute Providence Portland Medical Center
Bernard A. Fox, PhD, is the Harder Family Chair for Cancer Research, Member and Chief of the Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute (EACRI) and Robert W. Franz Cancer Center, at Providence Portland Medical Center; Co-founder and CEO of UbiVac, a clinical stage immuno-oncology company; and Adjunct Faculty, Oregon Health and Science University, Portland, Oregon. Dr. Fox received his B.S. in Biology and M.S in Immunology from the University of Detroit and his Ph.D. from Wayne State University, Detroit, Michigan. His postgraduate training was with Dr. Steven A. Rosenberg, Surgery Branch, NCI, NIH. His research efforts are divided between preclinical animal models, and the development, performance and monitoring of immunotherapy trials for patients with cancer and the training of the next generation of translational investigators. Dr. Fox has authored more than 160 peer-reviewed papers and book chapters, and has served as a member of review committees for the NIH, FDA, philanthropic and governmental organizations in the USA, Europe and Asia. Dr. Fox is the current Chair of the World Immunotherapy Council (WIC) and past President SITC. In 2015, Dr. Fox received the Visionary/Legacy Award from the Society for Immunotherapy of Cancer (SITC). www.finishcancer.org.